These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2309980)

  • 1. Chelation therapy and cardiac status in older patients with thalassemia major.
    Lerner N; Blei F; Bierman F; Johnson L; Piomelli S
    Am J Pediatr Hematol Oncol; 1990; 12(1):56-60. PubMed ID: 2309980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.
    Wolfe L; Olivieri N; Sallan D; Colan S; Rose V; Propper R; Freedman MH; Nathan DG
    N Engl J Med; 1985 Jun; 312(25):1600-3. PubMed ID: 4000198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation.
    Aldouri MA; Wonke B; Hoffbrand AV; Flynn DM; Ward SE; Agnew JE; Hilson AJ
    Acta Haematol; 1990; 84(3):113-7. PubMed ID: 2123060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained normalization of cardiac function by chelation therapy in thalassaemia major.
    Freeman AP; Giles RW; Berdoukas VA; Talley PA; Murray IP
    Clin Lab Haematol; 1989; 11(4):299-307. PubMed ID: 2605872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation.
    Miskin H; Yaniv I; Berant M; Hershko C; Tamary H
    Eur J Haematol; 2003 Jun; 70(6):398-403. PubMed ID: 12756023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in medically treated patients with homozygous beta-thalassemia.
    Olivieri NF; Nathan DG; MacMillan JH; Wayne AS; Liu PP; McGee A; Martin M; Koren G; Cohen AR
    N Engl J Med; 1994 Sep; 331(9):574-8. PubMed ID: 8047081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
    El-Beshlawy A; Manz C; Naja M; Eltagui M; Tarabishi C; Youssry I; Sobh H; Hamdy M; Sharaf I; Mostafa A; Shaker O; Hoffbrand AV; Taher A
    Ann Hematol; 2008 Jul; 87(7):545-50. PubMed ID: 18351337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine.
    Ehlers KH; Giardina PJ; Lesser ML; Engle MA; Hilgartner MW
    J Pediatr; 1991 Apr; 118(4 Pt 1):540-5. PubMed ID: 2007928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.
    Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2006; 30(2):219-27. PubMed ID: 16798647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.
    Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):41-7. PubMed ID: 18274982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate-term evaluation of a pratical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac t2*.
    Ha SY; Mok AS; Chu WC; Rasalkar DD; Cheuk DK; Chiang AK; Ho MH; Chan GC
    Hemoglobin; 2011; 35(3):199-205. PubMed ID: 21599432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
    Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
    Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.
    Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):332-8. PubMed ID: 19814679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron chelating therapy in thalassemia: current problems.
    Russo G
    Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ; Göbel U; Christaras A; Janssen G
    Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arrhythmia in thalassemia major: evaluation of iron chelating therapy by dynamic ECG].
    Cavallaro L; Meo A; Busà G; Coglitore A; Sergi G; Satullo G; Donato A; Calabrò MP; Miceli M
    Minerva Cardioangiol; 1993; 41(7-8):297-301. PubMed ID: 8233011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia.
    Kattamis C; Lagos P; Langona E
    Prog Clin Biol Res; 1979; 34():351-9. PubMed ID: 531060
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective evaluation of iron chelation therapy in children with severe beta-thalassemia. A six-year study.
    Maurer HS; Lloyd-Still JD; Ingrisano C; Gonzalez-Crussi F; Honig GR
    Am J Dis Child; 1988 Mar; 142(3):287-92. PubMed ID: 3344715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.